Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure

Journal of the American College of Cardiology

Volumn 36, Issue 3, 2000, Pages 838-844

  Tsutamoto, Takayoshi ^a   Wada, Atsuyuki ^a   Maeda, Keiko ^a   Mabuchi, Naoko ^a   Hayashi, Masaru ^a   Tsutsui, Takashi ^a   Ohnishi, Masato ^a   Sawaki, Masahide ^a   Fujii, Masanori ^a   Matsumoto, Takehiro ^a   Horie, Hajime ^a   Sugimoto, Yoshihisa ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE; VASODILATOR AGENT;

ALDOSTERONE BLOOD LEVEL; AORTA ROOT; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY SINUS; DRUG ACTIVITY; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE FIBROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ALDOSTERONE; ALDOSTERONE ANTAGONISTS; AORTA; CORONARY VESSELS; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PEPTIDE FRAGMENTS; PROCOLLAGEN; REFERENCE VALUES; SPIRONOLACTONE; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 0033852821     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00796-8     Document Type: Article

References (25)

1. Captopril in heart failure: A double-blind controlled trial
2. Rise in plasma concentration of aldosterone during long-term angiotensin II supression
3. ACE inhibitor co-therapy in patients with heart failure: Rationale for the Randomized Aldactone Evaluation Study (RALES)
4. Aldosterone escape during ACE inhibitor therapy in chronic heart failure
5. Antihypertensive therapy with MK421: Angiotensin II-renin relations to evaluate efficacy of converting enzyme blockade
6. Angiotensin II-forming pathways in normal and failing human hearts
7. Randomised trial of losartan versus captopril in patients over 65 with heart failure
8. The effect of spironolactone on mortality and morbidity in patients with severe heart failure
9. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system
10. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension
11. Left ventricular hypertrophy in asymptomatic essential hypertension: Its relationship with aldosterone and the increase in sodium-proton exchanger activity
12. Association between circulating components of the reninangiotensin-aldosterone system and left ventricular mass
13. Aldosterone and dexamethasone binding in human arterial smooth muscle cells
14. Prerequisite for cardiac aldosterone action: Mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase in the human heart
15. Tissue-specific expression of α- and β-messenger ribonucleic acid isoforms of the human mineralocorticoid receptor in normal and pathological states
16. Mineralocorticoids, hypertension, and cardiac fibrosis
17. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone
18. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor
19. Biological determinants of aldosterone-induced cardiac fibrosis in rats
20. Myocardial production of aldosterone and corticosterone in the rat
21. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
22. The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis
23. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis
24. The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarction
25. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients